Skip to search.
 TSX Down 0.39% TSX Ventures Up 0.28%

More On AEZS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
0.53 Down 0.02(2.75%) Mar 27, 4:00PM EDT
Add to Portfolio
Prev Close:0.55
Open:0.55
Bid:0.50 x 2000
Ask:0.61 x 4000
1y Target Est:1.48
Beta:2.63
Next Earnings Date:N/A
Day's Range:0.49 - 0.57
52wk Range:0.48 - 1.54
Volume:3,202,374
Avg Vol (3m):1,580,420
Market Cap:48.00M
P/E (ttm):N/A
EPS (ttm):-0.28
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
AEZSDown 2.75%48.00M
CELGUp 0.87%95.01B
ENMD 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,486.69
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.34
Quarterly EPS Est (Mar-15) :-0.10
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback